Nobil, Inc. – Trademark Portfolio

Entity Type: 03

Nobil, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 8 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. The owner is based in San Diego, CA.

550 West B Street, Suite 400

San Diego, CA 92101

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HVU+
HVU+
Abandoned 2021
HVR+
HVR+
Abandoned 2021
NOBIL
NOBIL
Abandoned 2021
N
N
Abandoned 2021
NOBIL
NOBIL
Abandoned 2021
N
N
Abandoned 2021

Trademark Classifications

Nobil, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (8 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (6 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

44
Medical Services (6 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Nobil, Inc. have?

Nobil, Inc. has 8 U.S. trademarks filed with the USPTO.

What trademark classes does Nobil, Inc. file in?

Nobil, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What is Nobil, Inc.'s trademark registration success rate?

Nobil, Inc. has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.